Company News: Johnson & Johnson (JNJ) Q3 EPS beat analysts’ estimate

Market news

18 October 2016

Company News: Johnson & Johnson (JNJ) Q3 EPS beat analysts’ estimate

Johnson & Johnson reported Q3 FY 2016 earnings of $1.68 per share (versus $1.49 in Q3 FY 2015), beating analysts' consensus estimate of $1.68.

The company's quarterly revenues amounted to $17.820 bln (+4.2% y/y), slightly beating analysts' consensus estimate of $17.745 bln.

The company issued raised guidance for FY2016, projecting EPS of $6.68-6.73, up from $6.63-6.73, versus analysts' consensus of $6.69; revenues are forecasted to amount to $71.5-72.2 bln versus analysts' consensus of $72.14 bln.

JNJ rose to $ 118.80 (+0.26%) in pre-market trading.

Orders

Company News: UnitedHealth (UNH) Q3 EPS beat analysts’ estimate

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.